The American Cancer Society reports that prostate cancer is the most common cancer found in men. It is estimated that about 220,000 new cases will be diagnosed in the U.S. in 2008, and about 27,000 of these men will die of the disease. These stats make prostate cancer the second leading cause of cancer death in men, second only to lung cancer.

Yet, while one man in six will get prostate cancer during his lifetime, just one in 34 will die of the disease. The death rate for prostate cancer is going down and the disease is being detected earlier overall.

Please join physicians from the Tuality/OHSU Cancer Center and Westside Urology Associates for a morning of information and discussion about prostate cancer, its diagnosis, and treatment.

Following a presentation at 9 a.m., physicians and staff from the Tuality/OHSU Cancer Center, Westside Urology Associates, and Tuality Healthcare, will provide free prostate specific antigen (PSA) blood tests. This early-detection screening tool can significantly increase the ability to find the disease in its early stages. Staff also will be on hand to help answer questions and provide educational information on prostate cancer and treatment options.

Tests will be processed by Tuality’s Laboratory Services, and results will be analyzed by radiation oncology physicians from the Tuality/OHSU Cancer Center. Their conclusions will be mailed to the participating men and their primary-care physicians during the following week.

For more information, contact Tina Dickerson, director, Tuality/OHSU Cancer Center, at 503-681-4200. Or visit the center’s Website at www.tuality-ohsu-cancercenter.org.

Presented by Tuality Healthcare, Westside Urology Associates LLP, and the Tuality/OHSU Cancer Center.